Global Incretin Mimetics Market Size, Status and Forecast 2021-2027

インクレチン模倣薬の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Incretin Mimetics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2361
◆調査・発行会社:QYResearch
◆発行日:2021年6月
◆ページ数:97
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、インクレチン模倣薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他)、用途別市場規模(固形腫瘍、血液関連腫瘍)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・インクレチン模倣薬の市場動向
・企業の競争状況、市場シェア
・インクレチン模倣薬の種類別市場規模(エキセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他)
・インクレチン模倣薬の用途別市場規模(固形腫瘍、血液関連腫瘍)
・インクレチン模倣薬の北米市場規模2016-2027(アメリカ、カナダ)
・インクレチン模倣薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・インクレチン模倣薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・インクレチン模倣薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・インクレチン模倣薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(GSK、Novo Nordisk、Lily、Haosoh、Sanofi、AstraZeneca)
・結論

Market Analysis and Insights: Global Incretin Mimetics Market
The global Incretin Mimetics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Incretin Mimetics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Incretin Mimetics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Incretin Mimetics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Incretin Mimetics market.

Global Incretin Mimetics Scope and Market Size
Incretin Mimetics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Incretin Mimetics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Exenatide
Liraglutide
Lixisenatide
Albiglutide
Others

Segment by Application
Solid Tumors
Blood-related Tumors

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GSK
Novo Nordisk
Lily
Haosoh
Sanofi
AstraZeneca

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Incretin Mimetics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Exenatide
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Others
1.3 Market by Application
1.3.1 Global Incretin Mimetics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Incretin Mimetics Market Perspective (2016-2027)
2.2 Incretin Mimetics Growth Trends by Regions
2.2.1 Incretin Mimetics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Incretin Mimetics Historic Market Share by Regions (2016-2021)
2.2.3 Incretin Mimetics Forecasted Market Size by Regions (2022-2027)
2.3 Incretin Mimetics Industry Dynamic
2.3.1 Incretin Mimetics Market Trends
2.3.2 Incretin Mimetics Market Drivers
2.3.3 Incretin Mimetics Market Challenges
2.3.4 Incretin Mimetics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Incretin Mimetics Players by Revenue
3.1.1 Global Top Incretin Mimetics Players by Revenue (2016-2021)
3.1.2 Global Incretin Mimetics Revenue Market Share by Players (2016-2021)
3.2 Global Incretin Mimetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Incretin Mimetics Revenue
3.4 Global Incretin Mimetics Market Concentration Ratio
3.4.1 Global Incretin Mimetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Incretin Mimetics Revenue in 2020
3.5 Incretin Mimetics Key Players Head office and Area Served
3.6 Key Players Incretin Mimetics Product Solution and Service
3.7 Date of Enter into Incretin Mimetics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Incretin Mimetics Breakdown Data by Type
4.1 Global Incretin Mimetics Historic Market Size by Type (2016-2021)
4.2 Global Incretin Mimetics Forecasted Market Size by Type (2022-2027)

5 Incretin Mimetics Breakdown Data by Application
5.1 Global Incretin Mimetics Historic Market Size by Application (2016-2021)
5.2 Global Incretin Mimetics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Incretin Mimetics Market Size (2016-2027)
6.2 North America Incretin Mimetics Market Size by Type
6.2.1 North America Incretin Mimetics Market Size by Type (2016-2021)
6.2.2 North America Incretin Mimetics Market Size by Type (2022-2027)
6.2.3 North America Incretin Mimetics Market Size by Type (2016-2027)
6.3 North America Incretin Mimetics Market Size by Application
6.3.1 North America Incretin Mimetics Market Size by Application (2016-2021)
6.3.2 North America Incretin Mimetics Market Size by Application (2022-2027)
6.3.3 North America Incretin Mimetics Market Size by Application (2016-2027)
6.4 North America Incretin Mimetics Market Size by Country
6.4.1 North America Incretin Mimetics Market Size by Country (2016-2021)
6.4.2 North America Incretin Mimetics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Incretin Mimetics Market Size (2016-2027)
7.2 Europe Incretin Mimetics Market Size by Type
7.2.1 Europe Incretin Mimetics Market Size by Type (2016-2021)
7.2.2 Europe Incretin Mimetics Market Size by Type (2022-2027)
7.2.3 Europe Incretin Mimetics Market Size by Type (2016-2027)
7.3 Europe Incretin Mimetics Market Size by Application
7.3.1 Europe Incretin Mimetics Market Size by Application (2016-2021)
7.3.2 Europe Incretin Mimetics Market Size by Application (2022-2027)
7.3.3 Europe Incretin Mimetics Market Size by Application (2016-2027)
7.4 Europe Incretin Mimetics Market Size by Country
7.4.1 Europe Incretin Mimetics Market Size by Country (2016-2021)
7.4.2 Europe Incretin Mimetics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Incretin Mimetics Market Size (2016-2027)
8.2 Asia-Pacific Incretin Mimetics Market Size by Type
8.2.1 Asia-Pacific Incretin Mimetics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Incretin Mimetics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Incretin Mimetics Market Size by Type (2016-2027)
8.3 Asia-Pacific Incretin Mimetics Market Size by Application
8.3.1 Asia-Pacific Incretin Mimetics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Incretin Mimetics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Incretin Mimetics Market Size by Application (2016-2027)
8.4 Asia-Pacific Incretin Mimetics Market Size by Region
8.4.1 Asia-Pacific Incretin Mimetics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Incretin Mimetics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Incretin Mimetics Market Size (2016-2027)
9.2 Latin America Incretin Mimetics Market Size by Type
9.2.1 Latin America Incretin Mimetics Market Size by Type (2016-2021)
9.2.2 Latin America Incretin Mimetics Market Size by Type (2022-2027)
9.2.3 Latin America Incretin Mimetics Market Size by Type (2016-2027)
9.3 Latin America Incretin Mimetics Market Size by Application
9.3.1 Latin America Incretin Mimetics Market Size by Application (2016-2021)
9.3.2 Latin America Incretin Mimetics Market Size by Application (2022-2027)
9.3.3 Latin America Incretin Mimetics Market Size by Application (2016-2027)
9.4 Latin America Incretin Mimetics Market Size by Country
9.4.1 Latin America Incretin Mimetics Market Size by Country (2016-2021)
9.4.2 Latin America Incretin Mimetics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Incretin Mimetics Market Size (2016-2027)
10.2 Middle East & Africa Incretin Mimetics Market Size by Type
10.2.1 Middle East & Africa Incretin Mimetics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Incretin Mimetics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Incretin Mimetics Market Size by Type (2016-2027)
10.3 Middle East & Africa Incretin Mimetics Market Size by Application
10.3.1 Middle East & Africa Incretin Mimetics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Incretin Mimetics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Incretin Mimetics Market Size by Application (2016-2027)
10.4 Middle East & Africa Incretin Mimetics Market Size by Country
10.4.1 Middle East & Africa Incretin Mimetics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Incretin Mimetics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Incretin Mimetics Introduction
11.1.4 GSK Revenue in Incretin Mimetics Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Incretin Mimetics Introduction
11.2.4 Novo Nordisk Revenue in Incretin Mimetics Business (2016-2021)
11.2.5 Novo Nordisk Recent Development
11.3 Lily
11.3.1 Lily Company Details
11.3.2 Lily Business Overview
11.3.3 Lily Incretin Mimetics Introduction
11.3.4 Lily Revenue in Incretin Mimetics Business (2016-2021)
11.3.5 Lily Recent Development
11.4 Haosoh
11.4.1 Haosoh Company Details
11.4.2 Haosoh Business Overview
11.4.3 Haosoh Incretin Mimetics Introduction
11.4.4 Haosoh Revenue in Incretin Mimetics Business (2016-2021)
11.4.5 Haosoh Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Incretin Mimetics Introduction
11.5.4 Sanofi Revenue in Incretin Mimetics Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Incretin Mimetics Introduction
11.6.4 AstraZeneca Revenue in Incretin Mimetics Business (2016-2021)
11.6.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Incretin Mimetics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Exenatide
Table 3. Key Players of Liraglutide
Table 4. Key Players of Lixisenatide
Table 5. Key Players of Albiglutide
Table 6. Key Players of Others
Table 7. Global Incretin Mimetics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Incretin Mimetics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Incretin Mimetics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Incretin Mimetics Market Share by Regions (2016-2021)
Table 11. Global Incretin Mimetics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Incretin Mimetics Market Share by Regions (2022-2027)
Table 13. Incretin Mimetics Market Trends
Table 14. Incretin Mimetics Market Drivers
Table 15. Incretin Mimetics Market Challenges
Table 16. Incretin Mimetics Market Restraints
Table 17. Global Incretin Mimetics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Incretin Mimetics Market Share by Players (2016-2021)
Table 19. Global Top Incretin Mimetics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Incretin Mimetics as of 2020)
Table 20. Ranking of Global Top Incretin Mimetics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Incretin Mimetics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Incretin Mimetics Product Solution and Service
Table 24. Date of Enter into Incretin Mimetics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Incretin Mimetics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Incretin Mimetics Revenue Market Share by Type (2016-2021)
Table 28. Global Incretin Mimetics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Incretin Mimetics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Incretin Mimetics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Incretin Mimetics Revenue Market Share by Application (2016-2021)
Table 32. Global Incretin Mimetics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Incretin Mimetics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Incretin Mimetics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Incretin Mimetics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Incretin Mimetics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Incretin Mimetics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Incretin Mimetics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Incretin Mimetics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Incretin Mimetics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Incretin Mimetics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Incretin Mimetics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Incretin Mimetics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Incretin Mimetics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Incretin Mimetics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Incretin Mimetics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Incretin Mimetics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Incretin Mimetics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Incretin Mimetics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Incretin Mimetics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Incretin Mimetics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Incretin Mimetics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Incretin Mimetics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Incretin Mimetics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Incretin Mimetics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Incretin Mimetics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Incretin Mimetics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Incretin Mimetics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Incretin Mimetics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Incretin Mimetics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Incretin Mimetics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Incretin Mimetics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Incretin Mimetics Market Size by Country (2022-2027) & (US$ Million)
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK Incretin Mimetics Product
Table 67. GSK Revenue in Incretin Mimetics Business (2016-2021) & (US$ Million)
Table 68. GSK Recent Development
Table 69. Novo Nordisk Company Details
Table 70. Novo Nordisk Business Overview
Table 71. Novo Nordisk Incretin Mimetics Product
Table 72. Novo Nordisk Revenue in Incretin Mimetics Business (2016-2021) & (US$ Million)
Table 73. Novo Nordisk Recent Development
Table 74. Lily Company Details
Table 75. Lily Business Overview
Table 76. Lily Incretin Mimetics Product
Table 77. Lily Revenue in Incretin Mimetics Business (2016-2021) & (US$ Million)
Table 78. Lily Recent Development
Table 79. Haosoh Company Details
Table 80. Haosoh Business Overview
Table 81. Haosoh Incretin Mimetics Product
Table 82. Haosoh Revenue in Incretin Mimetics Business (2016-2021) & (US$ Million)
Table 83. Haosoh Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Incretin Mimetics Product
Table 87. Sanofi Revenue in Incretin Mimetics Business (2016-2021) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Incretin Mimetics Product
Table 92. AstraZeneca Revenue in Incretin Mimetics Business (2016-2021) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Incretin Mimetics Market Share by Type: 2020 VS 2027
Figure 2. Exenatide Features
Figure 3. Liraglutide Features
Figure 4. Lixisenatide Features
Figure 5. Albiglutide Features
Figure 6. Others Features
Figure 7. Global Incretin Mimetics Market Share by Application: 2020 VS 2027
Figure 8. Solid Tumors Case Studies
Figure 9. Blood-related Tumors Case Studies
Figure 10. Incretin Mimetics Report Years Considered
Figure 11. Global Incretin Mimetics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Incretin Mimetics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Incretin Mimetics Market Share by Regions: 2020 VS 2027
Figure 14. Global Incretin Mimetics Market Share by Regions (2022-2027)
Figure 15. Global Incretin Mimetics Market Share by Players in 2020
Figure 16. Global Top Incretin Mimetics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Incretin Mimetics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Incretin Mimetics Revenue in 2020
Figure 18. Global Incretin Mimetics Revenue Market Share by Type (2016-2021)
Figure 19. Global Incretin Mimetics Revenue Market Share by Type (2022-2027)
Figure 20. North America Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Incretin Mimetics Market Share by Type (2016-2027)
Figure 22. North America Incretin Mimetics Market Share by Application (2016-2027)
Figure 23. North America Incretin Mimetics Market Share by Country (2016-2027)
Figure 24. United States Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Incretin Mimetics Market Share by Type (2016-2027)
Figure 28. Europe Incretin Mimetics Market Share by Application (2016-2027)
Figure 29. Europe Incretin Mimetics Market Share by Country (2016-2027)
Figure 30. Germany Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Incretin Mimetics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Incretin Mimetics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Incretin Mimetics Market Share by Region (2016-2027)
Figure 40. China Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Incretin Mimetics Market Share by Type (2016-2027)
Figure 48. Latin America Incretin Mimetics Market Share by Application (2016-2027)
Figure 49. Latin America Incretin Mimetics Market Share by Country (2016-2027)
Figure 50. Mexico Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Incretin Mimetics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Incretin Mimetics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Incretin Mimetics Market Share by Country (2016-2027)
Figure 56. Turkey Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Incretin Mimetics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GSK Revenue Growth Rate in Incretin Mimetics Business (2016-2021)
Figure 60. Novo Nordisk Revenue Growth Rate in Incretin Mimetics Business (2016-2021)
Figure 61. Lily Revenue Growth Rate in Incretin Mimetics Business (2016-2021)
Figure 62. Haosoh Revenue Growth Rate in Incretin Mimetics Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Incretin Mimetics Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Incretin Mimetics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[インクレチン模倣薬の世界市場規模・現状・予測2021年-2027年] (Global Incretin Mimetics Market Size, Status and Forecast 2021-2027 / QY21JNE2361)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆